Evidence map›Paper›PMID 37545572›Full record

ReviewFrontiers in nutrition2023

Recent updates on correlation between reactive oxygen species and synbiotics for effective management of ulcerative colitis.

Sumel Ashique, Neeraj Mishra, Ashish Garg, Belay Zeleke Sibuh, Pankaj Taneja, Gopal Rai, Sinouvassane Djearamane, Ling Shing Wong, Noura Al-Dayan, Shatabhisha Roychoudhury and 4 more

Abstract readReview
In one paragraph

Review in Frontiers in nutrition, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Modulation of Oxidative Stress and Nuclear Factor-κB- Associated Inflammatory Signaling by Rabeprazole in Acetic Acid-Induced Colonic InjuryThe Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2026
    Article
  6. Antioxidant and Anti-Inflammatory Activities of Probiotic Strains.International journal of molecular sciences · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Sumel AshiqueDepartment of Pharmaceutics, Pandaveswar School of Pharmacy, Pandaveswar, West Bengal, India.
Neeraj MishraAmity Institute of Pharmacy, Amity University Madhya Pradesh, Gwalior, India.
Ashish GargDepartment of P.G. Studies and Research in Chemistry and Pharmacy, Rani Durgavati University, Jabalpur, India.
Belay Zeleke SibuhDepartment of Biotechnology, Sharda School of Engineering and Technology, Sharda University, Greater Noida, India.
Pankaj TanejaDepartment of Biotechnology, Sharda School of Engineering and Technology, Sharda University, Greater Noida, India.
Gopal RaiDepartment of Pharmaceutics, Guru Ramdas Institute of Science and Technology, Jabalpur, India.
Sinouvassane DjearamaneDepartment of Biomedical Science, Faculty of Science, Universiti Tunku Abdul Rahman, Kampar, Malaysia.
Ling Shing WongFaculty of Health and Life Sciences, INTI International University, Nilai, Malaysia.
Noura Al-DayanDepartment of Medical Lab Sciences, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.
Shatabhisha RoychoudhuryHealth Centre, Assam University, Silchar, India.
Kavindra Kumar KesariFaculty of Health and Life Sciences, INTI International University, Nilai, Malaysia.
Petr SlamaLaboratory of Animal Immunology and Biotechnology, Department of Animal Morphology, Physiology and Genetics, Faculty of AgriSciences, Mendel University in Brno, Brno, Czechia.
Shubhadeep RoychoudhuryDepartment of Life Science and Bioinformatics, Assam University, Silchar, India.
Piyush Kumar GuptaFaculty of Health and Life Sciences, INTI International University, Nilai, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ulcerative colitis (UC) is presently considered a multifactorial pathology, which may lead to persistent inflammatory action of the gastrointestinal tract (GIT) because of an improperly managed immunological reactivity to the intestinal microbiota found in the GIT. The immune response to common commensal microbes plays an essential role in intestinal inflammation related to UC synbiotics, and it is an important element in the optimal therapy of UC. Therefore, synbiotics, i.e., a mixture of prebiotics and probiotics, may help control the diseased state. Synbiotics alleviate the inflammation of the colon by lowering the reactive oxygen species (ROS) and improving the level of antioxidant enzymes such as catalase (CAT), glutathione peroxidase (GPX), and superoxide dismutase (SOD). Prebiotic supplementation is not a common practice at the moment, despite numerous research findings proving that the benefits of both probiotics and prebiotics encourage their continued existence and positioning in the GIT, with positive effects on human health by managing the inflammatory response. However, the fact that there have been fewer studies on the treatment of UC with different probiotics coupled with selected prebiotics, i.e., synbiotics, and the outcomes of these studies have been very favorable. This evidence-based study explores the possible role of ROS, SOD, and synbiotics in managing the UC. The proposed review also focuses on the role of alteration of gut microbiota, antioxidant defense in the gastrointestinal tract, and the management of UC. Thus, the current article emphasizes oxidative stress signaling in the GI tract, oxidative stress-based pathomechanisms in UC patients, and UC therapies inhibiting oxidative stress' effects.

Indexed as

gut microbiotainflammationoxidative stresssuperoxide dismutasesynbioticsulcerative colitis

Identifiers

PMID37545572
PMCPMC10400011

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.